Carmen Scheibenbogen

Charité – Universitätsmedizin Berlin
Division of Immunodeficiency and Postinfectious Diseases
Institut für Med. Immunologie
Berlin | Germany

Carmen Scheibenbogen is an Internal Medicine physician specialized in hematooncology and immunology, Professor for Immunology and Director of the Division Immunodeficiency and Postinfectious Diseases at the Institute of Medical Immunology, Charité Universitätsmedizin in Berlin, Germany. She is co-founder of the COST-funded European network for ME/CFS EUROMENE, the Charité Fatigue Centre (https://cfc.charite.de), and the Post COVID Network Charité (https://pcn.charite.de). In 2022, she was awarded the Federal Cross of Merit for her commitment to ME/CFS.

Her research focuses on chronic fatigue syndrome (ME/CFS), Post Covid Syndrome, and immunodeficiencies and she has published more than 250 peer-reviewed papers. She has long-standing experience in immunotherapy both in conducting clinical trials and as a consultant in data safety monitoring boards. She is chair of the National Clinical Study Group NKSG, a clinical trial and research platform for ME/CFS and Post Covid (https://cfc.charite.de/klinische_studien/nksg/) and of the joint research project IMMME (immune mechanisms of ME/CFS, https://cfc.charite.de/forschung/immme/) trying to elucidate the role of GPCR antibodies in ME/CFS both funded by BMBF.